Cargando…

Aberrant Signaling Pathways in Squamous Cell Lung Carcinoma

Lung cancer is the second most commonly occurring non-cutaneous cancer in the United States with the highest mortality rate among both men and women. In this study, we utilized three lung cancer microarray datasets generated by previous researchers to identify differentially expressed genes, altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Ivy, Hashemi Sadraei, Nooshin, Duan, Zhong-Hui, Shi, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236010/ https://www.ncbi.nlm.nih.gov/pubmed/22174565 http://dx.doi.org/10.4137/CIN.S8283

Ejemplares similares

Comparative molecular profiling of HPV‐induced squamous cell carcinomas
por: Koncar, Robert F., et al.
Publicado: (2017)

Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
por: Haque, Sulsal, et al.
Publicado: (2017)

An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer
por: Patil, Pradnya Dinkar, et al.
Publicado: (2019)

Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma
por: Cacheux, Wulfran, et al.
Publicado: (2017)

Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway
por: Ju, Qianqian, et al.
Publicado: (2023)

Aberrant activation of the Hedgehog signalling pathway in squamous cell carcinoma of the vulva as a potential target for cancer therapy
por: Yap, Jason K. W., et al.
Publicado: (2021)

Aberrant methylation of EYA4 promotes epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
por: Luo, Mei, et al.
Publicado: (2018)

Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinoma
por: Jian, Hong, et al.
Publicado: (2019)

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma
por: Wise-Draper, Trisha, et al.
Publicado: (2017)

Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
por: Liu, Yinqiang, et al.
Publicado: (2023)

Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining
por: Chen, Wen-Jie, et al.
Publicado: (2017)

Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal‐regulated kinase signaling
por: Ge, Hong, et al.
Publicado: (2019)

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway
por: Huang, Wei, et al.
Publicado: (2021)

MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy
por: Cheng, Yuxi, et al.
Publicado: (2022)

Primary Squamous Cell Carcinoma of the Descending Colon
por: G Jahromi, Nooshin
Publicado: (2020)

Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
por: Niu, Zhenyi, et al.
Publicado: (2022)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
por: Zhu, Yuxuan, et al.
Publicado: (2019)

Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
por: Hirashima, K, et al.
Publicado: (2012)

Disruption of the Non-Canonical WNT Pathway in Lung Squamous Cell Carcinoma
por: Lee, Eric H.L., et al.
Publicado: (2008)

Aberrant Signaling Pathways in Glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2011)

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma
por: Li, Ting, et al.
Publicado: (2020)

ALK‐rearranged squamous cell carcinoma of the lung
por: Meng, Qiyi, et al.
Publicado: (2021)

Integrative genome‐wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma
por: Takemoto, Akira, et al.
Publicado: (2021)

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications
por: Lin, Lehang, et al.
Publicado: (2020)

Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach
por: Bak, So Hyeon, et al.
Publicado: (2018)

CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway
por: Xue, Feifei, et al.
Publicado: (2022)

Signaling Pathways Driving Aberrant Splicing in Cancer Cells
por: Gonçalves, Vânia, et al.
Publicado: (2017)

Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
por: Bongiovanni, Deborah, et al.
Publicado: (2017)

Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma
por: Chen, Fang-Fang, et al.
Publicado: (2019)

Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma
por: Zhao, Mengxiang, et al.
Publicado: (2019)

Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
por: Richter, Toni M, et al.
Publicado: (2005)

Inhibition of MUC1‐C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma
por: GongSun, Xin, et al.
Publicado: (2018)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
por: Jia, Bin, et al.
Publicado: (2022)

Development of alternative splicing signature in lung squamous cell carcinoma
por: Yan, Jia-qing, et al.
Publicado: (2021)

Mutational signatures in squamous cell carcinoma of the lung
por: Osoegawa, Atsushi, et al.
Publicado: (2021)

Squamous Cell Carcinoma of the Lung
por: Suarez, Eric, et al.
Publicado: (2017)

More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells
por: Zhang, Si-yang, et al.
Publicado: (2016)

Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells
por: Jin, Chengyan, et al.
Publicado: (2017)

Prognostic Value of Ki-67 Expression in Advanced Lung Squamous Cell Carcinoma Patients Treated with Chemotherapy
por: Wang, Diming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dmcui0ld9df0ivgg5c6glod38p